Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Significant Decrease in Short Interest

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the recipient of a significant decline in short interest in July. As of July 31st, there was short interest totaling 7,564 shares, a decline of 84.4% from the July 15th total of 48,491 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 247,388 shares, the short-interest ratio is currently 0.0 days.

Wall Street Analyst Weigh In

SGIOY has been the subject of several research analyst reports. The Goldman Sachs Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Monday, June 15th. Zacks Research raised Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research report on Monday, May 25th. Finally, Jefferies Financial Group upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Two equities research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy”.

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

SGIOY stock traded up $0.02 during trading hours on Friday, reaching $8.83. The stock had a trading volume of 47,587 shares, compared to its average volume of 137,745. Shionogi & Co., Ltd. Unsponsored ADR has a fifty-two week low of $7.65 and a fifty-two week high of $12.00. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.58 and a quick ratio of 1.46. The stock has a 50-day simple moving average of $8.78 and a 200 day simple moving average of $9.86. The stock has a market capitalization of $15.02 billion, a PE ratio of 8.83, a price-to-earnings-growth ratio of 3.48 and a beta of 0.08.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its earnings results on Monday, August 3rd. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.18. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 16.47% and a net margin of 46.67%.The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $970.69 million. Analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.79 EPS for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.